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Abstract 
Background: Psychiatric diseases severely affect the quality of patients’ lives and bring huge economic pressure to 
their families. Also, the great phenotypic variability among these patients makes it difficult to investigate the patho-
genesis. Nowadays, bioinformatics is hopeful to be used as an effective tool for the diagnosis of psychiatric disorders, 
which can identify sensitive biomarkers and explore associated signaling pathways.
Methods: In this study, we performed an integrated bioinformatic analysis on 1945 mental-associated proteins 
including 91 secreted proteins and 593 membrane proteins, which were screened from the Universal Protein 
Resource (Uniport) database. Then the function and pathway enrichment analyses, ontological classification, and 
constructed PPI network were executed.
Results: Our present study revealed that the majority of mental proteins were closely related to metabolic pro-
cesses and cellular processes. We also identified some significant molecular biomarkers in the progression of mental 
disorders, such as HRAS, ALS2, SLC6A1, SLC39A12, SIL1, IDUA, NEPH2 and XPO1. Furthermore, it was found that hub 
proteins, such as COMT, POMC, NPS and BDNF, might be the potential targets for mental disorders therapy. Finally, we 
demonstrated that psychiatric disorders may share the same signaling pathways with cancers, involving ESR1, BCL2 
and MAPK3.
Conclusion: Our data are expected to contribute to explaining the possible mechanisms of psychiatric diseases and 
providing a useful reference for the diagnosis and therapy of them.
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Background
Psychiatric disorders are generally regarded as neuropsy-
chological and neurobehavioral lesions, and the impaired 
ability to understand new or complicated information. It 
is estimated that more than 450 million people worldwide 
suffer from various mental disorders, among which major 
depression will be the most debilitating one by 2030 (World 
Health Organization 2010). Also, the appearance of psy-
chiatric disorders tends to take place in childhood with 
increasing prevalence and incidence. In addition, males 
with intellectual disability were even found to have an ele-
vated risk of leukemia, brain, stomach, corpus uteri and 
colorectal cancers (Sullivan et al. 2004). However, the eti-
opathogenesis of many psychiatric diseases is still unclear.
Two thirds of psychiatric patients take physical exami-
nation at primary care facilities. They always complain 
about the lack of energy as well as general aches and 
pains, so that their doctors usually focus on the organic 
disorders but neglect the mental problems. Moreover, 
most kinds of psychiatric disorders often present similar 
symptoms, which frequently delays the early evaluation 
of neurodevelopment status and disease progression. To 
this day, the diagnosis of psychiatric diseases has mainly 
depended on the daily living experience of patients’ 
families and the subjective expression of patients. There 
seems not to be available biological tests objectively 
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assessing the association between clinical symptoms and 
underlying molecular mechanisms.
Recently, with the development of bioinformatic tech-
nologies, we can get further insights into the pathogenesis 
of psychiatric disorders from the perspective of cells, cir-
cuits, and pathophysiological processes. And the recent 
findings of proteomic biomarker tests have made it more 
reliable and effective for the diagnosis and treatment of 
psychiatric disorders. For example, C-reactive protein 
(CRP) has been used as a biomarker to predict depres-
sion, and the increased CRP expression level was identi-
fied as an independent risk factor for de novo depression 
in women (Lopresti et  al. 2014; Wium-Andersen et  al. 
2013). Besides, cytokines, neopterin, malondialdehyde, 
isoprostanes, and serum S100B have also been reported 
to be reliable and sensitive biomarkers of mood disor-
der. (Howgren et  al. 2009; Rybka et  al. 2013; Maes et  al. 
2012; Chung et al. 2013; Milaneschi et al. 2013; Schroeter 
et al. 2013). Because multiple biological process overlap in 
the progression of psychiatric diseases, greater successes 
may be made on mental disease treatment by targeting 
the early biomarkers and the crucial signaling pathways. 
These successes should also be useful for exploring under-
lying mechanisms of mental disorders.
In this study, we aimed to explore the potential prot-
eomic biomarkers and pathological mechanisms in psy-
chiatric disorders with the help of bioinformatic tools. 
First, we performed a comprehensive bioinformatic 
analysis on the associated proteins from UniProt data-
base to determine their significant characteristics. Then 
the functional enrichment analyses and constructed PPI 
networks were carried out to identify key genes, proteins 
and signaling pathways. Psychiatric disorders investi-
gated in this study were referred to autism spectrum 
disorder (ASD), schizophrenia (SCZ), bipolar disorders, 
major depression, anxiety, phobia, affective disorder, 
obsessive compulsive disorder, personality disorder and 
mental retardation psychiatry. Proteins with altered 
expression which influence the physiological and patho-
logical progression of mental disorders may be involved 
in certain pathways.,. And once these pathways are made 
clear, it will help us know better about the pathogenic 
mechanisms and develop the targeted therapeutic strat-
egies. Therefore, bioinformatic classifications should be 
utilized as useful references for identification and charac-
terization of biomarkers, which will be expected to give a 
new direction to psychiatry research.
Results
Psychiatric‑disease‑associated proteins were screened 
and classified
We screened reviewed proteins from the UniProt data-
base and collected 2317 proteins associated with mental 
disorders. The retrieved proteins from various psychiat-
ric disorders were classified as follows: mental retarda-
tion (585 proteins), intellectual disability (425 proteins), 
cognitive disorder (94 proteins), autism (437 proteins), 
schizophrenia (413 proteins), bipolar disorder (219 pro-
teins), depression (63 proteins), anxiety (8 proteins), 
phobia (51 proteins), obsessive compulsive disorder (7 
proteins) and personality disorder (2 proteins). Because 
there are 372 proteins counted repeatedly among them, 
1945 proteins associated with human psychiatric diseases 
were obtained finally.
The associated proteins and signaling pathaways were 
identified by bioinformatic analysis
After the DAVID functional annotation clustering, a total 
of 1075 GO terms were found to be associated with psy-
chiatric diseases proteins. The implicative pathways of 
GO (top 20) were shown in Table 1. The result demon-
strated that mental-disorder-associated proteins mainly 
enriched in 2 GO categories including biological process 
(BP) and cellular component (CC). In the BP group, the 
majority (26%) of the proteins were concerned with met-
abolic processes, followed by cellular processes (21%). 
While the proteins in the CC group were comprised of 
cell part (43%), organelle (21%) and membrane (17%) 
(Fig. 1). And the top 5 pathways significantly involved in 
GO terms contained transmission of nerve impulse, neu-
ron projection, synaptic transmission, learning or mem-
ory and behavior.
By performing the KEGG analysis for enriched pro-
teins, we obtained 30 significant KEGG pathways with P 
value <0.05, and we showed the top 20 in Table 2. The top 
5 significant pathways were listed as follows: Neuroactive 
ligand-receptor interaction, Calcium signaling pathway, 
Long-term potentiation, Long-term depression, Prostate 
cancer.
Analysis of tissue specific proteins revealed that most 
of the proteins were expressed in brain (49%), epithelium 
(15.6%) and placenta (17%). In addition, there are 4 pro-
teins members of the VCX family expressed exclusively 
in testis.
Secretory proteins and cell surface proteins were identified
After retrieval of the “LOCATE” database, membrane 
organization analysis indicated that 1261 proteins were 
soluble proteins including 91 secreted proteins, and that 
593 proteins were membrane proteins containing 76 type 
I proeins, 168 type II proteins and 349 multiple trans-
membrane protein.
Hub proteins were identified by PPI network
PPI networks were established by Cytoscape software 
including 329 nodes and 1194 edges based on STRING 
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database. Then, the degree of all nodes was calculated 
and the proteins whose node degree >20 were shown as 
follows: POMC (proopiomelanocortin, Degree  =  41), 
NPS (neuropeptide S =  38), ESR1 (estrogen receptor 1, 
Degree  =  35), BDNF (brain-derived neurotrophic fac-
tor = 32), BCL2 (B-cell CLL/lymphoma 2 = 31), PTEN 
(phosphatase and tensin homolog, Degree  =  29), AR 
(androgen receptor  =  29), MAPK3 (mitogen-activated 
protein kinase 3, Degree  =  27), HDAC2 (histone dea-
cetylase 2  =  27), AVP (arginine vasopressin  =  24), 
CRH (corticotropin releasing hormone  =  24), COMT 
(catechol-O-methyltransferase, Degree  =  22), HTR2A 
(5-hydroxytryptamine receptor 2A =  21), ACTB (actin, 
beta  =  21), DPYD (dihydropyrimidine dehydroge-
nase =  21), MT-ND1 (mitochondrially encoded NADH 
dehydrogenase 1  =  21), DRD2 (dopamine receptor 
D2 = 21), CCK (cholecystokinin = 20), HTR7 (5-hydrox-
ytryptamine receptor 7 =  20). These hub proteins were 
displayed in Table  3 and the associated PPI networks 
were shown in Fig. 2.
Discussion
The diagnosis of psychiatric disorders always lack bio-
logical gold standards because of the complicated nosol-
ogy. The huge phenotypic variability in population also 
bring great challenges to explore credible biomarkers in 
the fields of drug abuse and neuropsychiatry researches. 
However, with the advancement of bioinformatic 
technology, a plenty variety of proteins have been 
explored to define different progression stages of mental 
diseases. We made full use of the information of psychiat-
ric-disease-associated proteins from the public databases 
and performed comprehensive bioinformatic analyses to 
determine sensitive biomarkers and significant signaling 
pathways. Our work is expected to provid new insights 
into the diagnosis of psychiatric diseases and investigate 
the underlying mechanisms. In future, more bioinfor-
matic data of mental diseases should be needed to evalu-
ate risks and benefits of specific therapeutic approaches 
and to enhance drug research and development.
In our study, 1945 mental-associated proteins were 
screened from the public database. Then we performed 
an integrated bioinformatic analysis to determine the 
biological relationship between these proteins and psy-
chiatric diseases. Ontological analysis demonstrated that 
most of the proteins, which could be classified into vari-
ous functional groups, may participate in different bio-
logical activities of brain. Functional clustering analysis 
also implied that these mental-associated proteins were 
significantly related to five GO terms: transmission of 
nerve impulse, neuron projection, synaptic transmis-
sion, learning or memory and behavior. We found trans-
mission of nerve impulse was the most important term 
enriched in psychiatric diseases, which played a funda-
mental role in dendritic morphology and electrophysi-
ological properties. And the second most important term 
Table 1 Top 20 GO function enrichment analysis of psychiatric diseases associated protein
Category Term Count P value
Biological process GO:0019226 : transmission of nerve impulse 91 2.89E−32
Cellular component GO:0043005: neuron projection 88 8.81E−32
Biological process GO:0007268: synaptic transmission 81 3.90E−30
Biological process GO:0007611: learning or memory 50 6.30E−30
Biological process GO:0007610: behavior 102 2.91E−29
Cellular component GO:0030424: axon 52 5.71E−24
Cellular component GO:0042995: cell projection 114 9.57E−23
Biological process GO:0007267: cell–cell signaling 102 1.18E−20
Biological process GO:0044057: regulation of system process 68 7.66E−20
Biological process GO:0007612: learning 30 1.37E−19
Cellular component GO:0045202: synapse 72 1.38E−19
Biological process GO:0031644: regulation of neurological system process 46 3.97E−19
Biological process GO:0042596: fear response 18 4.61E−19
Biological process GO:0051969: regulation of transmission of nerve impulse 44 3.08E−18
Biological process GO:0050877: neurological system process 153 6.80E−18
Biological process GO:0030900: forebrain development 44 1.22E−17
Cellular component GO:0030425: dendrite 45 1.25E−17
Biological process GO:0050804: regulation of synaptic transmission 41 3.77E−17
Biological process GO:0033555: multicellular organismal response to stress 23 4.65E−17
Biological process GO:0032990: cell part morphogenesis 57 5.83E−17
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neuron projection is associated with the transcription of 
ribosome-bound mRNA (Cook-Snyder et al. 2015). More 
than 80 proteins were identified in neuron projection 
term, and these proteins may influence metabolic pro-
cess or cellular process in mental disorders, such as STIL 
(SCL/TAL1 interrupting locus) and XPO1 (exportin 1). 
Besides, ALS2 (alsin Rho guanine nucleotide exchange 
factor) and SLC6A1 (solute carrier family 6 member 1), 
which were the most prominent proteins related to the 
majorty of top GO terms, could be valuable for the diag-
nosis and targeted therapy of psychiatry,. Many studies 
reported that common motor neuron diseases have a 
close relationship with mutations in ALS2, resulting in 
juvenile lateral sclerosis and infantile-onset ascending 
spastic paralysis (Sheerin et  al. 2014; Eker et  al. 2014). 
The neurotransmitter r-aminobutyric acid (GABA) trans-
porter 1, encoded by SLC6A1 gene, was verified as the 
most prominent biomarker in neural signal transduction 
pathways (Berg and Geschwind 2012). Nicola reported 
that even a tiny deletion of SLC6A1 gene could result in 
intellectual disability and multiple congenital anomalies 
(Dikow et al. 2014).
Through analysis of KEGG pathway enrichment, we 
finally got 30 significant pathways. Most of these path-
ways can be classified into two categories: neural signal 
transduction and cancer pathways. The neural signal 
transduction contains neuroactive ligand-receptor inter-
action pathway, calcium signaling pathway, long-term 
potentiation (LTP) and depression (LTD), gap junction, 
lysosome, Alanine, aspaetate and glutamate metabo-
lism. The most important neuroactive ligand-receptor 
interaction pathway has been applied into the assess-
ment of antipsychotic treatment and the analysis of neu-
ropsychiatric disorder model (Adkins et  al. 2012; Kong 
et al. 2015), which is enriched by TSPO, THRA, THRB, 
GABRB3, GRIK1, GABRB2, GRIK2, TRPV1, GABRB1, 
HTR6, OXTR. HRAS (harvey rat sarcoma viral onco-
gene homolog) was a predominant protein participating 
in 18 significant pathways. It may play key roles in psy-
chiatric disorders with pathological alteration. Schwartz 
mentioned that HRAS functioned in synaptic long-term 
potentiation (LTP) and memory formation (Schwartz 
et  al. 2013). It was demonstrated that the regulation of 
long-term potentiation is important for adult neuro-
genesis, synaptic plasticity, and learning and memory 
(Madroñal et al. 2010; Cooke and Bear 2010; Park et al. 
2015; Jing et  al. 2015). Therefore, HRAS is an ideal 
marker for psychiatric disorders diagnosis. While can-
cer pathways contained prostate cancer, thyroid can-
cer, chronic myeloid leukemia, melanoma, glioma, ErbB 
signaling pathway, and mTOR signaling pathway. These 
pathways remind us a fire-new angle to explore useful 
information from a mass of known proteins which were 
ignored before. MAPK3 is known as extracellular sig-
nal-regulated kinases (ERKs) and almost appears in all 
pathways. This gene always regulates a variety of cellular 
processes such as cell cycle progression, differentiation 
and proliferation. The overexpression of MAPK3 may 
indicate the pathogenesis of fear, anxiety and related psy-
chopathological conditions.
After the membrane organization analysis, 91 secreted 
proteins were predicted, which could be candidate pro-
teins for diagnosis of heritable mental diseases. For 
example, SLC39A12 (solute carrier family 39, member 
12), a putative zinc transporter gene, is highly expressed 
in adult brains. It can encode ZIP12 (zinc transporter 12) 
protein which is required for neurulation and neuronal 
development (Chowanadisai et  al. 2013; Chowanadi-
sai 2014). Any other protein including SIL1 (nucleotide 
exchange factor) precursor protein, IDUA (iduronidase), 
APP (amyloid beta precursor protein), NEPH2 (kin of 
IRRE-like protein), AOF2 (amine oxidoreductase), and 
Fig. 1 Broad functional classification of selected mental disorders-
associated proteins. a Biological processes, b cellular component
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WDR81 (WD repeat domain 81) proteins are expected 
to be diagnostic markers or therapeutic targets. And we 
found that 593 membrane proteins were transporters, 
receptors, enzymes and adhesion molecules, which were 
involved in nerve cell interactions, signaling transduction 
and energy metabolism.
Hub nodes have more complicated interactions with 
mental diseases compared with other proteins, imply-
ing that they paly a crucial part in mental disorders 
(Langfelder and Mischel 2013). Therefore, identifica-
tion of the hub proteins may enhance the assessment of 
disorders progression, neurodevelopment status, and 
therapeutic approaches. The following genes: POMC, 
NPS, ESR1, BDNF, BCL2, PTEN, AR, MAPK3, HDAC2, 
AVP, CRH, COMT, HTR2A, ACTB, DPYD, MT-ND1, 
DRD2, CCK, HTR7 were discovered as the genes that 
encode hub proteins in the PPI network. The POMC 
gene had a highest degree of 41, encoding the adren-
ocorticotropin hormone (ACTH) peptide, which 
brought our attention to major depressive disorders 
and the regulation of hypothalamic–pituitary–adrenal 
(HPA) axis function. POMC gene could be a valuable 
marker for assessing the response to antidepressant 
treatment (Chang et  al. 2015). Furthermore, the poly-
morphisms of COMT gene are associated with spo-
radic schizophrenia and mood disorder, respectively (Li 
et al. 2015; Pandolfo et al. 2015). COMT inhibitors had 
been used to ameliorate symptoms of parkinson’s dis-
ease (Müller 2015). Therefore, POMC and COMT are 
both potential pharmacological targets for treating psy-
chiatric disorders.
The NPS and BDNF genes also have multidirectional 
physiological activities in brain. Recent studies showed 
that NPS was associated with the regulation of food 
intake, fear, addiction and anxiety (Oishi et al. 2014; Slat-
tery et al. 2015; Wegener et al. 2012). Dine et al. showed 
NPS application to mouse brain slices activated neu-
rotransmission and plasticity in hippocampal CA3 and 
CA1 synapses (Dine et  al. 2013). And the strong anxio-
lytic effect of NPS may be concerned with the increased 
dopamine releasing in medial prefrontal cortex (Lukas 
Table 2 The enriched KEGG pathways of psychiatric disorders
Term Description Count P value
KEGG:04080 Neuroactive ligand-receptor interaction 54 2.15E−10
KEGG:04020 Calcium signaling pathway 34 6.88E−06
KEGG:04720 Long-term potentiation 18 3.01E−05
KEGG:04730 Long-term depression 18 3.70E−05
KEGG:05215 Prostate cancer 19 3.37E−04
KEGG:04540 Gap junction 18 9.74E−04
KEGG:04150 mTOR signaling pathway 12 0.003294
KEGG:05012 Parkinson’s disease 21 0.004578
KEGG:05216 Thyroid cancer 8 0.008593
KEGG:05220 Chronic myeloid leukemia 14 0.008781
KEGG:00250 Alanine, aspartate and glutamate metabolism 8 0.012514
KEGG:04012 ErbB signaling pathway 15 0.012769
KEGG:05218 Melanoma 13 0.014087
KEGG:05214 Glioma 12 0.014554
KEGG:05200 Pathways in cancer 40 0.015047
KEGG:00563 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 7 0.015127
KEGG:05010 Alzheimer’s disease 23 0.016819
KEGG:04916 Melanogenesis 16 0.017224
KEGG:04142 Lysosome 18 0.017275











HTR2A, ACTB, DPYD, MT-ND1, DRD2 21
CCK, HTR7 20
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and Neumannid 2012; Si et  al. 2010). The BDNF gene 
encodes a few proteins of nerve growth factor families, 
involving the process of neurogenesis and the realiza-
tion of neuroprotective functions. It was also found that 
BDNF played a key role in memory and learning organi-
zation and motor function. The expression of BDNF 
protein always decreases in patients with degenerative 
and vascular dementias, anxiety, affective and behavio-
ral disorders (Levada and Cherednichenko 2015). Jehn 
et al. indicated that the low-level expression of BDNF was 
associated with cognitive impairment and short-term 
memory, coupled with the increased IL-6, which would 
be implicated in pathophysiology of depression patients 
(Jehn et al. 2015). NPS and BDNF could be used as neu-
robiological markers in pathological process, and the 
increased concentration may provide a potential novel 
treatment option.
Increased references in PubMed also provided us other 
hub proteins involved in cancer pathways, such as ESR1, 
PTEN, BCL2, AR and MAPK3. The down-regulation of 
BDNF-Akt-Bcl2 anti-apoptotic signaling pathway could 
be responsible for pathogenesis of autism. (Sheikh et al. 
2010) Borges also reported that ERK1/2 signaling path-
way effectively regulate depression, anxiety and emotion 
(Borges et  al. 2015). Therefore, these potential targets 
involved in cancers may share the same signaling path-
way with mental disorders. To ascertain the accurate 
roles of these genes may clarify pathological mechanisms 
and provide valuable information for psychiatric therapy.
Conclusions
This study analyzed mental-associated proteins out of the 
reviewed database to explore the molecular mechanisms 
of psychiatric diseases by using bioinformatic methods. 
Fig. 2 The constructed PPI network of psychiatric diseases. Nodes represent proteins, edges represent interactions between two proteins
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Our findings are expected to contribute to determining 
mental biomarkers, such as secreted proteins SLC39A12, 
SIL1, IDUA, APP, NEPH2, AOF2, and WDR81. And hub 
proteins, such as POMC, COMT, NPS, BDNF, also have 
the potential to be applied as targets for the diagnosis and 
treatment of mental disorders.
Methods
Screen of psychiatric diseases associated proteins
The UniProt (Release 2011_10, http://www.uniprot.org) 
was used to screen psychiatric diseases associated pro-
teins. All human proteins were extracted from the UniProt 
database involving all annotations, such as “mental retar-
dation”, “intellectual disability”, “autism”, “Schizophrenia”, 
“bipolar disorder”, “major depression”, “anxiety”, “phobia”, 
“affective disorder”, “obsessive compulsive disorder”, and 
“personality disorder”. Then the associated proteins were 
further filtrated manually from the downloaded data.
Enrichment bioinformatic analysis
Protein IDs were submitted to DAVID (http://david.
abcc.ncifcrf.gv/), a platform for functional analysis, such 
as gene ontologies, protein domains, and pathways. Of 
these, the enrichment analysis of GO categories includes 
biological process (BP), molecular function (MF), and 
cellular component (CC). The P value was computed by 
right-sided hypergeometric tests, GO terms were consid-
ered significance with P value <0.01, and KEGG pathways 
with P value <0.05. Protein IDs extracted from UniProt 
also were uploaded to PANTHER (www.pantherdb.org) 
to identify molecular function and protein class term 
through gene expression tools.
Analysis of the membrane organization
The LOCATE (http://locate.imb.uq.edu.au/), a curated 
database, was used to describe membrane organization 
of proteins. Uniprot IDs of mental illness proteins were 
uploaded to the LOCATE server to select secretory and 
cell surface proteins, which are promising biomarkers.
PPI network construction and hub proteins identification
The STRING database, a Search Tool to pre-compute 
global resource and evaluate protein–protein interac-
tions information (von Mering et  al. 2003), was used 
to construct PPI networks. And we primarily analyzed 
screened proteins of human psychiatric diseases by the 
UniProt database. Then, we performed analysis for PPI 
networks using Geniscape of Cytoscape software (ver-
sion: 3.2.1) (Shannon et al. 2003). From a previous docu-
ment on biological networks, numbers of PPI networks 
subjected to the scale-free attribution (Lamb et al. 2006). 
Therefore, connectivity degree was calculated by statis-
tics and important nodes in PPI networks were obtained, 
namely hub proteins. Finally, the node degree >20 was 
selected as the threshold to obtain hub proteins in our 
study.
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